Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib

MLA

Alexander Roesch, et al. Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6530414.

APA

Alexander Roesch, Dirk Schadendorf, Eduard Gasal, Elisabeth Livingstone, Lisa Zimmer, Kurt W. Schmid, Antje Sucker, Jacob Schachter, Boguslawa Karaszewska, Keith T. Flaherty, Antoni Ribas, Paul D. Nathan, Georgina V. Long, Caroline Robert, Ken Schultz, Naveen Dakappagari, Ju Kim, Deborah Castelletti, Renata Varaljai, … Jan C. Brase. (2023). Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. https://doi.org/10.1158/1078-0432.c.6530414

Chicago

Alexander Roesch, Dirk Schadendorf, Eduard Gasal, Elisabeth Livingstone, Lisa Zimmer, Kurt W. Schmid, Antje Sucker, et al. 2023. “Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib,” March. doi:10.1158/1078-0432.c.6530414.